← Leaderboards
Burton M Wice
Washington University
$3,456,634
Attributed
$3,706,633
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,706,633 · 7
By mechanism
R01$2,318,617 · 1
RC1$999,035 · 1
R21$306,000 · 1
P60$82,981 · 4
Top collaborators
- Kenneth S Polonsky1 shared
Most similar at Washington University
Same institution · by research overlap
- Philip E. Cryer$4,377,949
- Bettina Mittendorfer$14,806,767
- Samuel Klein$33,055,933
- Jeffrey Ivan Gordon$32,802,915
- Dan A Jacobson$13,435
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusSmall IntestinesInsulinInterestGlucose ToleranceInsulin SecretionIncidenceElementsEconomic BurdenHuman SubjectEnteroendocrine CellExhibitsGastric Inhibitory Polypeptide ReceptorCostAmericanDiagnosisCaringGlucoseBaseCellsAcetylcholineHealth Care QualityEngineeringInfusion Procedures
Grant awards (13)
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION$448,297
R01 · FY2014 · DK · contact PI
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION$432,606
R01 · FY2013 · DK · contact PI
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION$448,297
R01 · FY2012 · DK · contact PI
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION$448,297
R01 · FY2011 · DK · contact PI
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION$541,120
R01 · FY2010 · DK · contact PI
A PROOF-OF-CONCEPT CLINICAL TRIAL OF XENIN-25 IN THE TREATMENT OF TYPE 2 DIABETES$499,036
RC1 · FY2010 · DK · contact PI
A PROOF-OF-CONCEPT CLINICAL TRIAL OF XENIN-25 IN THE TREATMENT OF TYPE 2 DIABETES$499,999
RC1 · FY2009 · DK
TRANSGENICS CORE$82,981
P60 · FY2006 · DK · contact PI
TRANSGENICS CORE$0
P60 · FY2005 · DK
Engineering Insulin Production by K-Cells to Treat T1DM$153,000
R21 · FY2004 · DK
TRANSGENICS CORE$0
P60 · FY2004 · DK
Engineering Insulin Production by K-Cells to Treat T1DM$153,000
R21 · FY2003 · DK
CORE--TRANSGENIC$0
P60 · FY2003 · DK